Literature DB >> 1534442

Cardiovascular risk factors in chronic renal failure and hemodialysis populations.

K W Ma1, E L Greene, L Raij.   

Abstract

Cardiovascular disease is the leading cause of death in patients with end-stage renal disease (ESRD). Risk factors for cardiovascular disease, including hypertension, lipid abnormalities, left ventricular hypertrophy (LVH), and glucose intolerance, are present more frequently in patients with chronic renal failure than in the general population, even before the onset of replacement therapy. The prevalence, pathogenesis, and significance of these factors in the uremic population are examined, and the potential roles of intervention are reviewed. Evidence suggests, but is not conclusive, that these factors are of predictive value for cardiovascular complications in patients with chronic renal failure. The effect of modification of these factors on cardiovascular morbidity and mortality in this population, especially in the early stages of renal failure, is an important area for further study.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1534442     DOI: 10.1016/s0272-6386(12)80827-4

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  24 in total

1.  NADPH oxidase-derived reactive oxygen species contribute to impaired cutaneous microvascular function in chronic kidney disease.

Authors:  Jennifer J DuPont; Meghan G Ramick; William B Farquhar; Raymond R Townsend; David G Edwards
Journal:  Am J Physiol Renal Physiol       Date:  2014-04-23

2.  Serum cadmium levels are independently associated with endothelial function in hemodialysis patients.

Authors:  Yuksel Kaya; Elif Ari; Halit Demir; Ilhan Gecit; Ali Beytur; Cigdem Kaspar
Journal:  Int Urol Nephrol       Date:  2011-09-09       Impact factor: 2.370

3.  A randomized, double-blind, placebo-controlled trial of spironolactone on carotid intima-media thickness in nondiabetic hemodialysis patients.

Authors:  Antonio Vukusich; Sonia Kunstmann; Cristian Varela; Daniela Gainza; Sebastian Bravo; Daniela Sepulveda; Gabriel Cavada; Luis Michea; Elisa T Marusic
Journal:  Clin J Am Soc Nephrol       Date:  2010-06-03       Impact factor: 8.237

4.  Association of echocardiographic abnormalities with mortality in men with non-dialysis-dependent chronic kidney disease.

Authors:  Jason Payne; Smriti Sharma; Dexter De Leon; Jun L Lu; Fregenet Alemu; Rasheed A Balogun; Sandra M Malakauskas; Kamyar Kalantar-Zadeh; Csaba P Kovesdy
Journal:  Nephrol Dial Transplant       Date:  2011-05-25       Impact factor: 5.992

5.  Lowering dialysate sodium improves systemic oxidative stress in maintenance hemodialysis patients.

Authors:  Beyza Macunluoglu; Hasan Ali Gumrukcuoglu; Aydin Atakan; Halit Demir; Hamit Hakan Alp; Aytac Akyol; Serkan Akdag; Ahmet Yavuz; Zehra Eren; Sıddık Keskin; Elif Ari
Journal:  Int Urol Nephrol       Date:  2016-07-29       Impact factor: 2.370

6.  Effects of lowering dialysate sodium on carotid artery atherosclerosis and endothelial dysfunction in maintenance hemodialysis patients.

Authors:  Hasan Ali Gümrükçüoğlu; Elif Arı; Aytaç Akyol; Serkan Akdağ; Hakkı Simşek; Musa Sahin; Yılmaz Güneş; Mustafa Tuncer
Journal:  Int Urol Nephrol       Date:  2012-01-14       Impact factor: 2.370

7.  Cinacalcet may improve oxidative DNA damage in maintenance hemodialysis patients: an observational study.

Authors:  Elif Ari; Yuksel Kaya; Halit Demir; Ebru Asicioglu; Zehra Eren; Eray Celik; Hakki Arikan
Journal:  Int Urol Nephrol       Date:  2014-05-09       Impact factor: 2.370

8.  The relationship between arteriovenous fistula blood flow rate and pulmonary artery pressure in hemodialysis patients.

Authors:  Gursel Acarturk; Ramazan Albayrak; Mehmet Melek; Seref Yuksel; Ihsan Uslan; Huseyin Atli; Mehmet Colbay; Mehmet Unlu; Fatma Fidan; Zerrin Asci; Soner Cander; Ozcan Karaman; Murat Acar
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.370

9.  Effect of different dialysis modalities on microinflammatory status and endothelial damage.

Authors:  Ana Merino; José Portolés; Rafael Selgas; Raquel Ojeda; Paula Buendia; Javier Ocaña; M Auxiliadora Bajo; Gloria del Peso; Julia Carracedo; Rafael Ramírez; Alejandro Martín-Malo; Pedro Aljama
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-07       Impact factor: 8.237

10.  Prognostic predictors and outcomes in patients with abnormal myocardial perfusion imaging and angiographically insignificant coronary artery disease.

Authors:  Fadi Alqaisi; Firas Albadarin; Zehra Jaffery; Leonidas Tzogias; Muath Dawod; Gordon Jacobsen; Karthik Ananthasubramaniam
Journal:  J Nucl Cardiol       Date:  2008-07-31       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.